ClinicalTrials.gov
public full text
Public Domain
Microalbuminuria and Allopurinol in Type 1 Diabetes
The objective is to determine if lowering serum uric acid by means of allopurinol in the course of kidney disease may be effective in preventing or improving albuminuria and renal function in Type 1 Diabetic patients. The study is a double blinded, randomised, placebo-controlled cross-over clinical trial.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Effect of Sulodexide in Early Diabetic Nephropathy#894871
- Validation of Biomarkers of Diabetic Nephropathy in Type I Diabetic Children#979245
- A Crossover Study With Hexalacton in Patients With Type 1 Diabetes and Microalbuminuria#152595
- Effect of Sulodexide on Albuminuria in Chinese Type 2 Diabetic Patients#913129
- Association of Variability of Monthly Continuous Glucose Monitoring-Derived Metrics With Diabetic Kidney Disease in Type 1 Diabetes.#645336
Record · ID 1351420
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive